(Q77676392)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851653%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Riluzole has no acute effect on motor unit parameters in ALS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851653%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

7 December 2019

main subject

1 reference

J Desai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851653%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Sharief

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851653%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Swash

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851653%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851653%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851653%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

160 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851653%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

S69-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851653%20AND%20SRC:MED&resulttype=core&format=json

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Fasciculation potentials: a study of amyotrophic lateral sclerosis and other neurogenic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Glutamate neurotoxicity and diseases of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Fasciculations: what do we know of their significance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

The pharmacology and mechanism of action of riluzole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Excitatory amino acid-induced release of 3H-GABA from cultured mouse cerebral cortex interneurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Fasciculations in motor neuron disease: discharge rate reflects extent and recency of collateral sprouting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Abnormal glutamate metabolism in amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Excitotoxicity and motor neurone disease: a review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Riluzole: a new agent for amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

Fasciculation potentials in foot and leg muscles of healthy young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900201-9

10.1016/S0022-510X(98)00201-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9851653%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference